external milieu. The most important investigative contribution of Bernard was the discovery of a glucoregulatory system that maintains the constancy of glucose in the milieu intefieur. This review will focus on both contributions -glucose constancy and the glucoregulatory system that maintains it. The teleology of glucose constancy, the physiology of the glueoregulatory system, that is the insulin-glucagon relationships, the signals that control the insulinglucagon relationship, and, finally, the pathophysiology of glucoregulation in diabetes will be dealt with in turn. Initially, however, the glucoregulatory system as Bernard himself might have viewed it will be examined.
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The 1853 Bernard Model of Glucoregulation
On March 17, 1853, before the Faculty of Science of Paris, Bernard gave his zoology dissertation entitled "Recherches sur une nouvelle fonction du foie, consider6 comme organe producteur de mati~re sucr6e chez l'homme et les animaux" [1] . He introduced the then heretical idea that animals, like plants, could synthesize glucose, and, indeed, that continuous production of glucose by the liver was a characteristic of mammalian life. "Sugar," he said, "is poured by the liver into the blood, and, just like sugar of alimentary origin, must be constantly assimilated and ~:onverted into other products." With that sentence he had introduced the concept of glucose flux and turnover. Bernard might indeed have sketched his concept of the system of glucoregulation in the manner of Because of his piqfire experiments five years earlier [2] he was convinced that glucose flux rates were regulated by the central nervous system through a balance of opposing forces: "nerfs desassimilateurs", that stimulate hepatic glucose production, and "nerfs assimilateurs" that stimulate glucose uptake.
Model of Glucoregulation
Let us now compare this Bernardian model with an updated 1980 model of the glucoregulatory system incorporating information accumulated during the intervening 127 vears (Fig. 2 ). There are modifications but, remarkably, the basic design remains relatively intact. The pancreatectomy experiments of Minkowski in 1889 [3] , 40years after Bernard's piqfire experiments and 11 years after his death. required a relocation of the controls of glucoregulation from the central nervous system to the pancreatic islets. During the current century glucagon and insulin have replaced, respectively, the "nerfs desassimilateurs" and "'assimilateurs". Ironically, however, ever since the Pearse hypothesis (see [4] for. review), the islets have seemed increasingly like specialized ganglionic extensions of the central nervous system, all of their four known secretory products having been identified in the central nervous system proper [5] [6] [7] . Clearly, the brain own control the sectetion of all four islet pcptidcs through the adrenergic. cholinergic and perhaps peptidergic pathways as elucidated by the groups of Bloom [8] , Porte [9] , Frohman [101 and others. Perhaps Bernard's 1853 choice of the central nervous system as the site of the control over gtucorcgulation may ultimately be vind: cated.
Teleology of Glucose Constancy
Bernard was struck by the constancy of the glucose levels in the dog, irrespective of whether it was in a postprandial or a fasting state. Similarly, in normal humans there is a remarkable constancy of the glucose profile of normal humans [Ill, which remains between 60 and 180 mg/dl (3.3 to 10 mmol/l) irrespective of the rate of glucose intake or utilization. Today we think we understand the teleology of this glucose constancy, a question left unanswered by Bernard. The normal function of the human brain requires approximately 6g of glucose per hour. Evolutionary success reqmres presumably a foolproof guarantee of these fuel requirements of the central nervous system both in time of tranquility and during survival crises, such as fight, flight, famine, or injury. The fact that 6 g of glucose per hour can be delivered to the brain only if the arterial glucose con-.centration is maintained above 50 mg/dl may explain why this level is so staunchly defended, The equatlS~ vigorous defense against hyperglycaemia may reflect the fact.that hyperglycaemia interferes with normal control of glycosytation, a care.fully regulated posttranslational process by which certain proteins derive their special structural and functional characteristics [12] . Excessive glycosylation caused by chronic hyperglycaemia can modify the structure and functions of proteins, sometimes with adverse consequences, as Spiro has discussed in a previous Claude Bernard Lecture [13] . Thus, Cerami and his colleagues incubated crystallin lens protein with higln concentrations of glucose or glucose-6-phosphate [ 14] . After 28 davs they observed the development ol opalescence and other changes similar to those of in vivo cataract development. glucose utilization by intense muscular effort drains glucose from the milieu interieur. Unless it is promptly replaced by increased hepatic glucose production, hypoglycaemia would occur. However, adrenergic control over the islets stimulates glucagon secretion and enhanced hepatic glucose production, while it suppresses insulin release to minimize glucose outflow to tissues other than brain and exercising muscle Thus, normoglycaemia and cerebral glucose delivery is preserved despite the massive increase in glucose effiux, b Severe injury: Durin$ injury cerebral hypoperfusion resulting from hypovolaemic shock compromises the delivery of glucose to the brain. Stress hyperglycaemia a compensatory response, is produced through adrenergic enhancement of glucagon secretion, to stimulate glucose production, ant inhibition of insulin secretion to curtail glucose efflux into insulin-sensitive tissues, liver, muscle and fat. Thus, all endogenously producec glucose is conserved for utilization by the brain and other insulin-independent tissues, and "fixity" of the internal milieu sacrificec temporarily during the acute threat to life provide both a unifying biochemical link between hyperglycaemia [15] and diabetic tissue damage and an attractiv.e explanation for nature's rigorous efforts to keep the glucose concentration below 200 mg/dt. Indeed, a study in Pima Indians [t6] indicates that 200 mg/dl is precisely the level above.which a quantitative relationship between postprandial hypergtycaemia and the incidence of retinopathy appears within 6 years. Thus, it seems that the rationale for the avoidance of glucose lows and highs may be, respectively, inadequate cerebral fuel delivery and overglycosylation of proteins with deleterious consequences.
Physiological Mechanisms of Glucose Constancy
Let us now consider mechanisms by which a large amount of glucose can move into or out of the milieu interieur without violating these concentration boundaries under widely varying circumstances, such as the basal state, a survival crisis, and during a meal. Constancy of concentration during marked inconstancy of flux can be maintained only by means of a "push-pull" system similar to that envisioned by Bernard -one that can always maintain an equality of the glucose that enters and the glucose that leaves the milieu, irrespective of the magnitude of a change in either. This equilibrium is achieved through the coordinated antagonism of glucagon and insulin [17, 18] , which control the rates, respectively, of glucose influx and glucose efflux. (Fig. 2) About 75% of hepatic glucose production in the basal state is glucagon-mediated [19] . Seventy five percent of the 10 g of glucose produced hourly by the human liver is more than enough for the hourly glucose requirement (6 g per hour) of the human brain. This suggests a vital relationship between the A-cell, and the brain. Vidnes and Oyasaeter have reported the only known case of glucagon deficiency, an infanl with intractable and ultimately fatal hypoglycaemia who responded for several weeks to glucagot replacement [20] . One can wonder, therefore, iJ glucagon-mediated basat glucose production may no be essential for life, at least in the perinatal period.
The Basal State

In Survival Crises (Fight and Flight, Injury, Farninej
Survival requires that cerebral glucose needs be me: in time of crisis, as well as at rest. Situations of figh and flight constitute two common survival crise~ (Fig. 3a) . In both, instant and intense muscula: response greatly augments glucose utilization anc would quickly cause hypogtycaemia were glucose no replaced as fast as it is used. In such circumstance~ 
. Glucoregulation during meals:
Glucose influx from the gut is preceded by an appropriately timed and quantitated insulin release mediated by GI hormones and vagal and perhaps peptidergic signals to the islets. This anticipatory response of insulin permits glucose uptake by insulin responsive tissues to proceed almost as rapidly as glucose absorption, an "open-loop" type of insulin delivery arrangement. At the same time, somatostatin secretion may serve to coordinate nutrient influx from the gut with insulin-controlled glucose efflux from the circulation, providing further assurance against perturbation of nutrient concentrations clearly the central nervous system, in responding to the crisis, instantly assumes complete control of islet function [21] [22] [23] [24] . Adrenergicalty stimulated glucagon secretion increases glucose production so as to replace precisely the extra glucose used by muscle, while simultaneous adrenergic suppression of insulin secretion serves, to prevent the endogenously pro-. duced ~ucose from entering the insulin-responsive tissues, such as fat and liyer, in which it.is not important in such circumstances.
After serious injury ( Fig. 3b) , hypovolaemic shock will reduce cerebral blood flow and, thereby, glucose delivery will be diminished. Survival may depend on the ability of the glucoregulatory system to deliver glucose to a hypoperfused brain. This can be accomplished only by a rise in arterial glucose levels. Thus, if arterial glucose concentration is doubled, a 50% decline in cerebral blood flow can be tolerated without a net reduction in glucose delivery to the brain. In this manner, stress-induced hyperglycaemia, the endogenous equivalent of a glucose infusion, may help to prolong life until the crisis has passed. Once again the central nervous system, in response to the danger, takes full command of islet function [25] [26] [27] . Adrenergic stimulation of glucagon and suppression of insulin secretion stimulate glucose production by the liver in a setting in which glucose efflux to tissues other than central nervous system is minimized, thus preventing glucose wastage in the tissues for which it is not essential. These adrenergic signals can maintain stress hyperglycaemia for as long as is desirable by overriding the gtucagon-suppressing and insulin-stimulating effects of the hyperglycaemia and thus preventing its self-correction through the feedback controls that operate in the unstressed state. In addition to direct neural control over the islets, the stress hormones, growth hormone Finally, in starvation, when protein conservation becomes critical to survival, the same high glucagonlow insulin mixture [31] serves the needs of the brain b+ mobilizing fatty acids (see 32 for review). This reduces glucose utilization through the Randle glucose-fatty acid cycle and yields substrate for ketogenesis, a glucagon-mediated process [33] that provides a substitute fuel for the brain. Once again, through these simple, changes in the gtucagon-insulin mixture, the complex fuel needs of the brain and other tissues are adjusted with remarkable precision to cope with environmental changes.
In the Fed State (The "Enteroinsular System")
If the defense against hypoglycaemia depends heavily on the glucagon response, the defense against postprandial hyperglycaemia depends on appropriate timing and quantity of the insulin response to each meal. All nutrients, including glucose, are very weak stimuli of insulin secretion, especially when their concentration is in the low normal range. Avoidance of a high postprandial nutrient level, therefore, requires an "open loop" type of insulin delivery system capable of preventing as well as reacting to and correcting such perturbations (Fig. 4) . The B-cell must, there-. fore, anticipate, rather than simply respond to, an inflowing glucose tide. The term "enteroinsular axis" has been applied to meal-induced humoral signals to the islets secreted by the gastrointestinal tract [34]. and perhaps peptidergic signals, orchestrate an anticipatory pattern of insulin release that promotes uptake of the inftowing substrates by these insulin-sensitive tissues almost as fast as they enter. These signals, which were previously assigned a secondary role in the prandial insulin response to nutrients, may well provide the primary stimulus, at least in the early phase response. However, if nutrient concentrations approach or exceed the upper limits of normal, then they themselves begin to elicit a self-correcting "closed loop" type of insulin response. Gut hormones also stimulate somatostatin release in parallel with that of insulin [39] , and, it has been postulated that somatostatin, like insulin, may be involved in the maintenance of nutrient constancy after meals [40] . Somatostatin restrains the secretion of the gut hormones [41--48] that stimulate it, thus suggesting a complete positive-negative feedback circuit between gut and islets (Fig. 4) [49] . This action of somatostatin and its other direct inhibitory actions on a broad range of digestive functions [44-48, 50, 51] , provide a means by which the islets can control the rate at which ingested nutrients cross from the external environment of the gut lumen into the internal milieu of the body [52, 53] . The striking parallel~sm between somatostatin and insulin secretion [39] suggests a coupling between D-and B-cells (Fig. 5) ; such coupling could minimize postprandial perturbation of nutrient concentrations by coordinating the influx of ingested nutrients with their insulin-mediated efflux. Or, in addition, is an exchange of signals between the islet cells themselves required for the production o'f the appropriately titrated secretion mixtures produced by the normal islets? Signals between islet cells could be transmitted by two routes, first, across intervenmg interstitial spaces, the paracrine route first suggested by Feyrter [54] , and/or, second, through their gap junctions [55] .
Paracrine Signals
The nonrandom distribution of the islet cells creates a heterocellular region of contiguity between A-cells, D-cells and the outer tier of B-cells in which paracrine pathways would be possible [56, 57] . Additionally, the fact that glucagon stimulates both B- [58] and D-cells [59] , insulin inhibits A-cells [60] and somatostatin inhibits both A- [61] and B-cells [62] provides the functional basis for the existence of such a system. There is, for example, powerful evidence that A-and B-cells may modulate each others' secretory activity, through the positive-negative feedback arrangements described by Samols 15 years ago [58, 60] (Fig. 6) . A short paracrine feedback loop could regulate the timing and composition of the insulin and glucagon mixture and thus titrate more precisely their antagonist actions on hepatic glycogenolysis, gluconeogenesis and ketogenesis. Thus, the glucagon released during a protein meal can shift glucose from the liver into the peripheral tissues without an important increase in the blood glucose level because insulin secretion is stimulated concurrently, rather than after glycogenolysis. Conversely , during a glucose load insulin can dil:ectly suppress glucagon secretidn while it is opposing the actions of glucagon on "the liver; there is indeed impressive, if indirect, evidence that gluc0se-induced suppressiofl of glucagon secretion is entirely mediated by insulin. In the absence of insulin, the A-cell behaves as if it has no real glucose sensor of its own, or, as Buchanan first showed [63] , it responds paradoxically to hyperglycaemia.
Gap Junction Signals
A second possible route of islet cell-to-islet cell information exchange is via their gap junctions, first described by Orci et al. [64] . Meda et al. have shown that cyclic nucleotides can pass from one islet cell to another without entering the islet interstitium [65] .
Ions and other small molecules may do the same. Thus, gap junctions may link all the cellular components of the islets to form a functional syncytium, but their precise role is still unidentified.
Pathophysiology in Diabetes
The same model used to examine the normal glucoregulatory systems can be used to examine the pathophysiology of the diabetic state. In 1859 Ber-nard aptly summarized the pathophysiology of diabetes in three brief sentences: "In diabetes the liver oversecretes. The matter changed there to sugar cannot be transformed into a more complex product. Desassimilation," as he referred to glycogenolysis and other catabolic processes, "has become preponderant" [66] (Fig. 7) . Bernard's emphasis on the role of "desassimilation" or glucose overproduction in diabetic hyperglycaemia was disputed for almost a century, before its rediscovery and acceptance in relatively recent times. Today, it is recognized that overproduction of glucose relative to its utilization, is the cause of endogenous hyperglycaemia. Whereas Bernard attributed the disequilibrium between glucose influx and efflux to a preponderance of the "nerfs desassimilateurs" relative to the '~ assimilateurs", we, at least some of us, attribute it to a preponderance of glucagon [67] [68] [69] [70] [71] [72] action relative to insulin action, irrespective of the absolute concentration of either hormone in pg/ml [72] [73] [74] (Fig. 8) . In Type I (insulin dependent) diabetes the relative hyperglucagonaemia is secondary to an absence or paucity of B-cells. The loss of the restraining influence of coupled insulin secretion upon the A-cells results in a bihormonal abnormality [73, 74] , i. e, a combination of insulin lack and retative or absolute hyperglucagonaemia (Table 1) . Both abnormalities contribute to the metabolic syndrome of uncontrolled diabetes. Insulin lack is to blkme for. the extrahepatic abnorr:nalities: reduced glucose utilization by the insulin sensitive tissues, and increased proteolysis and lipolysis, i. e., release of amino acids from muscle and fatty acids from adipocytes. Hyperglucagonaemia (or biologically glucagon-like substances other than glucagon) appears to be essential for the hepatic abnormalities of diabetes: increased glycogenolysis, gluconeogenesis and ketogenesis (see [74] for review). The insulin lack in and of itself plays no direct role in this overproduction of glucose and ketones, other than to allow the unrestrained secretion and action of glucagon and/or epinephrine [75] . McGarry and Foster (personal communication) have convincing new in vitro evidence that insulin's only action of the liver is to oppose glucagon, so that in the absence of glucagon, the presence or absence of insulin is irrelevant with respect to hepatic fuel production. This supports the earlier in vivo work by Gerich in man [76] , Cherrington et al. in dogs [77] and ourselves in both dogs [78] and man [79, 80] . As shown in Figure 9 , when both insulin and glucagon are essentially zero, as during a somatostatin infusion in an insulin-deprived Type I diabetic, massive hepatic overproduction of fuels does not occur; glucose levels remain well below 180 mg/dl and there is no glycosuria or ketonuria. In patients in whom insulin was clamped at approximately 25 uU/ ml for three days, hyperglyeaemia, glycosuria and ketonuria increased progressively as glucagon levels rose as the result of a constant low-dose glucagon infusion. Thus in the absence of glucagon deficiency of insulin does not result in massive overproduction of fuels by the liver. Data adapted from Gerich et al. [76] and from Raskin and Unger [80] GLUCAGON § KEzo.Es Fig. 10 . The absence of a sufficient number of B-cells eliminates the normal inhibitory effect of insulin on the A-cell (see Figure 6 ) and both paracrine and gap junctional coupling with B-cells is lacking. The resulting hyperglucagonaemia stimulates glucose and ketone production in the liver without opposition from insulin. The resulting hyperglycaemia can neither be corrected by compensatory insulin-mediated uptake in tissues nor reduced by inhibition of glucagon secretion, since this too is an insulin-requiring process
On the other hand, in such diabetics even with insulin levels clamped for 24 h at the normal basal level of 25 gU/ml, small progressive increments in glucagon produced by glucagon infusion increase hepatic glucose and ketone body production, as reflected by an increase in hyperglycaemia level and a massive increase in glycosuria and ketonuria. These results illustrate the importance of the normal coupling between A-and B-cells. When an increase in glucagon is not accompanied by the normal, appropriately timed increase in insulin (Fig. 10 ) that occurs when normal B-cells are linked functionally to A-cells, then a rise in glucagon will cause hyperglycaemia. In the absence of a rise in insulin, this hyperglycaemia cannot be quickly taken up in peripheral tissues and cannot suppress glucagon. Thus, the all-important glucoregulatory feedback loop is severed. However, appropriately timed and quantitated replacement of insulin via the open loop system pioneered by Pickup et al. [81] , corrects both abnormalities, the insulin lack and the relative hyperglucagonaemia [82] . The glucose profile becomes normal. Thus, the bihormonal defect has responded to unihormonal replacement with insulin.
The bihormonal defect is also present in noninsulin dependent diabetes, but here its mechanism must be different. In contrast-to the ease with which all the A-cell abnormalities of "insulin-dependent diabetes can be corrected with insulin, in most noninsulin dependent diabetics insulin fails to correct the exaggerated glucagon secretion [83, 84] , although it reduces the basal glucagon levels [85] . In these patients, of course, there is no absolute deficiency of insulin; indeed, it is often abundant. Conceivably in some cases of non-insulin dependent diabetes there is insulin resistance in both A-cells and B-cells to the inhibitory effects of insulin on both insulin and glucagon secretion with resulting hypersecretion of both hormones. Alternatively, a relative local deficiency of somatostatin as described in ob/ob mice [86] could be an aetiologic factor in certain cases. These and other hypotheses can be tested in the second postBernardian century just beginning.
A Look at the Second Post-Bernardian Century
I have attempted to provide a panoramic view of concepts of the glucoregulatory system, as they have evolved from the time of Claude Bernard to the end of the first century after his death.
The full implications of the concepts of Claude Bernard and those of Charles Darwin for medical science have yet to be fully recognized or applied, even as we enter the second post-Bernardian century in which astounding progress in medicine is occurring at other levels. Claude Bernard had predicted "... that in a hundred years physiology would enable man to make laws for organisms and carry out human creation in competition with the Creator himself," [87] , but it is not clear if he recognized the enormous potential power for human health of his own simple concept of fixity of the internal milieu. He saw it as essential for the "free life", but did not to my knowledge, equate it with health in the medical sense. Rather, it was Walter Cannon, who first emphasized that "health... depends on what are called homeostatic processes..." Nor did Bernard seem to see a link between his concept of fixity of the milieu interieur and the ideas of Darwin. According to both Virtanen [88] and Olmstead [89] , Bernard's attitude toward evolution and Darwinism was noncommittal or even adverse -he regarded it as "speculative and of no use for the physician." He had little interest in hypotheses that did not lead to experimental verification.
Yet, the combined ideas expressed by these two men may hold more hope for future health of man through disease prevention than any powerful new therapy of the future designed to reverse the endstage biologic catastrophes that fill our hospital beds today. Consider the following premises: first, cells have adapted over millions of years in an optimally fixed medium and their health and species survival constitute evidence of their compatability with their environment. Second, any modification to the milieu from that in which a cell line has evolved will place them at risk, that may be expressed as malfunction, disease or death. Third, most modifications of the internal milieu today are induced by man, rather than by nature; therefore, theoretically they are preventable.
A chronology of man's increasing ability to modify both his internal and external environments is given in Table 2 in relation to his principal health problems. It should be noted that this depressing list of man-made pathogenic environmental modifications includes two items, the last two on the list, of specific interest to the diabetologist. These are obesity and its relationship to Type II (non-insulin dependent) diabetes, and the introduction of insulin used ir a way that prevents the death of Type I diabetics but permits chronic metabolic derangements. Like ever) other environmental modification on the list, both ol these are preventable. But, man's ability to modif) his environment appears to be infinitely more powerful than his will to restore it to its original constancy Indeed, after 40 years of debate, diabetologists dc not yet agree that efforts to restore the milieu tc normal are even warranted. 
